Transcriptional activation of the human stress-inducible transcriptional repressor ATF3 gene promoter by p53

Biochemical and Biophysical Research Communications

Volumn 297, Issue 5, 2002, Pages 1302-1310

  Zhang, Chun ^a   Gao, Choungfeng ^a   Kawauchi, Junya ^a   Hashimoto, Yoshinori ^a   Tsuchida, Nobuo ^a   Kitajima, Shigetaka ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

ATF3; DNA binding; p53; Promoter element; Stress response; Target gene; Transcriptional repressor

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 3; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; PROTEASOME INHIBITOR; PROTEIN P53; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; GENE TARGETING; HUMAN; HUMAN CELL; NULL ALLELE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; STRESS; TEMPERATURE SENSITIVE MUTANT; TEMPERATURE SENSITIVITY; TRANSCRIPTION INITIATION; ULTRAVIOLET RADIATION;

ACTIVATING TRANSCRIPTION FACTOR 3; ALLELES; BLOTTING, WESTERN; CYSTEINE ENDOPEPTIDASES; CYSTEINE PROTEINASE INHIBITORS; GENES, P53; GENES, REPORTER; HUMANS; LEUPEPTINS; MODELS, GENETIC; MULTIENZYME COMPLEXES; MUTATION; PLASMIDS; PROMOTER REGIONS (GENETICS); PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN BINDING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TEMPERATURE; TIME FACTORS; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; ULTRAVIOLET RAYS;

EID: 0036402458     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(02)02382-3     Document Type: Article

References (38)

1. A.J. Levine, P53, the cellular gatekeeper for growth and division, Cell 88 (1997) 323-331.
2. C. Prives, P.A. Hall, The p53 pathway, J. Pathol. 187 (1999) 112-126.
3. S. Fields, S.K. Jang, Presence of a potent transcription activating sequence in the p53 protein, Science 249 (1990) 1046-1049.
4. J. Raycroft, H.Y. Wu, G. Lozano, Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene, Science 249 (1990) 1049-1051.
5. S.E. Kern, K.W. Kinzler, A. Bruskin, D. Jarosz, P. Friedman, C. Prives, B. Vogelstein, Identification of p53 as a sequence-specific DNA-binding protein, Science 252 (1991) 1708-1711.
6. W.S. el-Deiry, S.E. Kern, J.A. Pietenpol, K.W. Kinzler, B. Vogelstein, Definition of a consensus binding site for p53, Nat. Genet. 1 (1992) 45-49.
7. J.A. Pietenpol, T. Tokino, S. Thiagalingam, W.S. el-Deiry, K.W. Kinzler, B. Vogelstein, Sequence-specific transcriptional activation is essential for growth suppression by p53, Proc. Natl. Acad. Sci. USA 91 (1994) 1998-2002.
8. N.P. Pavletich, K.A. Chambers, C.O. Pabo, The DNA-binding domain of p53 contains the four conserved regions and the major mutation hot spots, Genes Dev. 7 (1993) 2556-2564.
9. W.S. el-Deiry, T. Tokino, V.E. Velculescu, D.B. Levy, R. Parsons, J.M. Trent, D. Lin, W.E. Mercer, K.W. Kinzler, B. Vogelstein, WAF1, a potential mediator of p53 tumor suppression, Cell 75 (1993) 817-825.
10. J.W. Harper, G.R. Adami, N. Wei, K. Keyomarsi, S.J. Elledge, The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases, Cell 75 (1993) 805-816.
11. M.B. Kastan, Q. Zhan, W.S. el-Deiry, F. Carrier, T. Jacks, W.V. Walsh, B.S. Plunkett, B. Vogelstein, A.J. Fornace Jr., A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia, Cell 71 (1992) 587-597.
12. R. Zhao, K. Gish, M. Murphy, Y. Yin, D. Notterman, W.H. Hoffman, E. Tom, D.H. Mack, A.J. Levine, Analysis of p53-regulated gene expression patterns using oligonucleotide arrays, Genes Dev. 14 (2000) 981-993.
13. K. Kannan, N. Amariglio, G. Rechavi, J. Jakoab-Hirsch, I. Kela, N. Kaminski, Z. Getz, E. Domany, D. Givol, DNA microarrays identification of primary and secondary target genes regulated by p53, Oncogene 20 (2001) 2225-2234.
14. T. Hai, C.D. Wolfgang, D.K. Marsee, A.E. Allen, U. Sivaprasad, ATF3 and stress responses, Gene Expression 7 (1999) 321-335.
15. B.P.C. Chen, C.D. Wolfgang, T. Hai, Analysis of ATF3, a transcription factor induced by physiological stresses and modulated by gadd153/Chop10, Mol. Cell. Biol. 16 (1996) 1157-1168.
16. A.A. Shtil, S. Mandlekar, R. Yu, R.I. Walter, K. Hagen, T.-H. Tan, I.B. Roninson, A.-N.T. Kong, Differential regulation of mitogen-activated protein kinases by microtubule-binding agents in human breast cancer cells, Oncogene 18 (1999) 377-384.
17. J. Zimmermann, D. Erdmann, I. Lalande, R. Grossenbacher, M. Noorani, P. Furst, Proteasome inhibitor induced gene expression profiles reveal overexpression of transcritpional regulators ATF3, GADD153 and MAD1, Oncogene 19 (2000) 2913-2920.
18. S.A. Amundson, M. Bittner, Y. Chen, J. Trent, P. Meltzer, A.J. Fornace, Fluorescent cDNA microarray hybridization reveals complexity and heterogeneity of cellular genotoxic stress response, Oncogene 18 (1999) 3666-3672.
19. Y. Cai, C. Zhang, T. Nawa, T. Aso, M. Tanaka, S. Oshiro, H. Ichijo, S. Kitajima, Homocysteine-responsive ATF3 gene expression in human vascular endothelial cells: activation of c-Jun NH2 terminal kinase and promoter response element, Blood 96 (2000) 2140-2148.
20. T. Yin, G. Sandhu, C.D. Wolfgang, A. Burrier, R.L. Webb, D.F. Rigel, T. Hai, J. Whelan, Tissue-specific pattern of stress kinase activation in ischamic/reperfused heart and kidney, J. Biol. Chem. 272 (1997) 19943-19950.
21. C. Yan, H. Wang, D.D. Boyd, ATF3 represses 72 kDa type IV collagenase (MMP-2) expression by antagonizing p53-dependent trans-activation of the collagenase promoter, J. Biol. Chem. 277 (2002) 10804-10812.
22. J. Kawauchi, C. Zhang, K. Nobori, Y. Hashimoto, T.M. Adachi, A. Noda, M. Sunamori, S. Kitajima, Transcriptional repressor ATF3 protects human umbilical vein endothelial cells from TNF-α-induced apoptosis through down-regulation of p53 transcription, J. Biol. Chem. (2002), in press.
23. K. Yamato, M. Yamamoto, Y. Hirano, N. Tsuchida, A human temperature-sensitive p53 mutant p53Val-138: modulation of the cell cycle, viability and expression of p53-responsive genes, Oncogene 11 (1995) 1-6.
24. F. Bunz, A. Dutriaux, C. Lengauer, T. Waldman, S. Zhou, J.P. Brown, J.M. Sedivy, K.W. Kinzler, B. Vogelstein, Requirement for p53 and p21 to sustain G2 arrest after DNA damage, Science 282 (1998) 1497-1501.
25. O.H. Lowry, N.J. Rosebrough, A.L. Farr, R.J. Randall, Protein measurement with folin phenol reagent, J. Biol. Chem. 193 (1951) 265-275.
26. G. Liang, C.D. Wolfgang, P.C. Benjamin, T-H. Chen, T. Hai, ATF3 gene. genomic organization, promoter, and regulation, J. Biol. Chem. 271 (1996) 1695-1701.
27. M. Murphy, A. Hinman, A.J. Levine, Wild-type p53 negatively regulates the expression of a microtubule-associated protein, Genes Dev. 10 (1996) 2971-2980.
28. Q. Wang, G.P. Xambetti, D.P. Suttle, Inhibition of DNA topoisomerase IIa gene expression by the p53 tumor suppressor, Mol. Cell. Biol. 17 (1997) 389-397.
29. Y. Sun, Y. Sun, L. Wenger, J.L. Rutter, C.E. Brinckerhoff, H.S. Cheung, p53 down-regulates human matrix metalloproteinase-1 (collagenase-1) gene expression, J. Biol. Chem. 274 (1999) 11535-11540.
30. Y. Sun, J.M. Cheung, J. Martel-Pelletier, J.P. Pelletier, L. Wenger, R.D. Altman, D.S. Howell, H.S. Cheung, Wild type and mutant p53 differentially regulate the gene expression of human collagenase-3 (hMMP-13), J. Biol. Chem. 275 (2000) 11327-11332.
31. B.P.C. Chen, G. Liang, J. Whelan, T. Hai, ATF3 and ATF3 delta Zip. Transcriptional repression versus activation by alternatively spliced isoform, J. Biol. Chem. 269 (1994) 15819-15826.
32. T.W. Fawcett, J.L. Martindale, K.Z. Guyton, T. Hai, N.J. Holbrook, Complexes containing ATF/CREB interact with the C/EBP-ATF composite site to regulate GADD153 expression during the stress response, Biochem. J. 339 (1999) 135-141.
33. T. Nawa, T.M. Nawa, Y. Cai, C. Zhang, I. Uchimura, S. Narumi, F. Numano, S. Kitajima, Repression of TNF-α-induced E-selectin expression by PPAR activators: involvement of transcriptional repressor LRF-1/ATF3, Biochem. Biophys. Res. Commun. 87 (2000) 565-576.
34. C. Zhang, J. Kawauchi, T.M. Adachi, Y. Hashimoto, S. Oshiro, T. Aso, S. Kitajima, Activation of JNK and transcriptional repressor ATF3/LRF1 through the IRE1/TRAF2 pathway is implicated in human vascular endothelial cell death by homocysteine, Biochem. Biophys. Res. Commun. 289 (2001) 718-724.
35. J.-C. Hsu, T. Laz, K.L. Mohn, R. Taub, Identification of LRF-1, a leucine-zipper protein that is rapidly and highly induced in regenerating liver, Proc. Natl. Acad. Sci. USA 88 (1991) 3511-3515.
36. V.R. Iyer, M.B. Eisen, D.T. Ross, G. Schuler, T. Moore, J.C.F. Lee, J.M. Trent, L.M. Staudt, J. Hudson, M.S. Boguski, D. Lashkari, D. Shalon, D. Botstein, P.O. Brown, The transcriptional program in the response of human fibroblasts to serum, Science 283 (1999) 83-87.
37. T. Ishiguro, M. Nakajima, M. Naito, T. Muto, T. Tsuruo, Identification of genes differentially expressed in B6 murine melanoma sublines with different metastatic potentials, Cancer Res. 56 (1996) 875-879.
38. S. Perez, E. Vial, H. van Dam, M. Castellazzi, Transcription factor ATF3 partially transforms chick embryo fibroblasts by promoting growth factor-independent proliferation, Oncogene 20 (2001) 1135-1141.